Verigraft AB
Verigraft is a biotechnology company based in Gothenburg, Sweden, focused on regenerative medicine and personalized tissue therapies. The company develops proprietary technology to create personalized, tissue-engineered grafts for transplantation, aiming to eliminate rejection and improve patient outcomes. With a strategic R&D pipeline targeting cardiovascular and neuronal diseases, Verigraft is working towards global commercialization of its innovative products, which have the potential to treat previously incurable diseases and significantly impact quality of life.
Industries
Nr. of Employees
small (1-50)
Products
Personalized tissue-engineered vein graft (clinical-stage)
A patient-personalized human vein segment engineered to contain a functional venous valve for transplantation to replace defective vein segments; currently evaluated in Phase I/II clinical studies for chronic venous insufficiency.
Personalized tissue-engineered arterial graft (preclinical/early clinical)
A personalized arterial graft candidate intended for vascular reconstruction and bypass applications; development ranges from preclinical to early clinical stages.
Personalized tissue-engineered peripheral nerve graft (preclinical)
A personalized graft designed to bridge peripheral nerve defects and support reinnervation over long gaps; development in preclinical stages.
Personalized tissue-engineered heart valve candidate (preclinical)
A fully biological heart valve concept personalized to the patient, intended to provide an alternative to prosthetic valves, particularly for younger patients and children.
Personalized tissue-engineered vein graft (clinical-stage)
A patient-personalized human vein segment engineered to contain a functional venous valve for transplantation to replace defective vein segments; currently evaluated in Phase I/II clinical studies for chronic venous insufficiency.
Personalized tissue-engineered arterial graft (preclinical/early clinical)
A personalized arterial graft candidate intended for vascular reconstruction and bypass applications; development ranges from preclinical to early clinical stages.
Personalized tissue-engineered peripheral nerve graft (preclinical)
A personalized graft designed to bridge peripheral nerve defects and support reinnervation over long gaps; development in preclinical stages.
Personalized tissue-engineered heart valve candidate (preclinical)
A fully biological heart valve concept personalized to the patient, intended to provide an alternative to prosthetic valves, particularly for younger patients and children.
Services
R&D collaboration and consortium participation
Collaborative research projects with academic and industry partners for preclinical development, scaffold and process development, and grant-funded programs.
Clinical development and trial sponsorship
Design and sponsor oversight of Phase I/II clinical trials for personalized tissue grafts, including safety monitoring and TMF management.
Manufacturing process development and CMO partnership
Development of production processes for personalized grafts and management of outsourced manufacturing partners to enable clinical and commercial supply.
R&D collaboration and consortium participation
Collaborative research projects with academic and industry partners for preclinical development, scaffold and process development, and grant-funded programs.
Clinical development and trial sponsorship
Design and sponsor oversight of Phase I/II clinical trials for personalized tissue grafts, including safety monitoring and TMF management.
Manufacturing process development and CMO partnership
Development of production processes for personalized grafts and management of outsourced manufacturing partners to enable clinical and commercial supply.
Expertise Areas
- Tissue engineering and regenerative medicine
- Vascular graft development
- Clinical trial management for ATMPs
- Bioprocessing and manufacturing scale-up
Key Technologies
- Tissue engineering
- Decellularization and recellularization
- Autologous blood-derived recellularization
- 3D printing of biomaterial scaffolds